Episyringaresinol 4-O-beta-D-glncopyranoside ((-)-Syringaresinol 4-O-beta-D-glucopyranosi) inhibits the proliferation of human promyelocytic HL-6 cells through G(1) arrest and induction of apoptosis, and may be a potential chemotherapeutic agent for cancer treatment.
Molecular Weight:
580.58
Purity:
99.89%
CAS Number:
[137038-13-2]
Formula:
C28H36O13
Target:
Others
TMS0484
* VAT and and shipping costs not included. Errors and price changes excepted